Report Highlights
The global metabolomics market should reach $22.7 billion by 2026 from $12.7 billion in 2021 at a compound annual growth rate (CAGR) of 12.3% for the forecast period of 2021 to 2026.
Report Includes
- 59 tables
- An overview and industry analysis of the global markets for metabolomics technologies
- Analyses of global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Assessment of the key marketed products and recent product launches, regulatory landscape across different demographics covering North America, Europe, Asia-Pacific, Latin America and Middle East
- Coverage of history and pathways of metabolomics, information on metabolomes and their sources like large bowel microflora, urine metabolome, food metabolome and comparison between lipidomes and lipidomics
- Highlights of the market potential for metabolomics market by product, indication, application, and region; assessment of investment in metabolomic research and spending in pharmaceutical and biotech R&D
- Information on targeted and untargeted approaches for metabolomic technology and complexity associated with data examination and processing
- Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
- Detailed profiles of the leading companies in the metabolomics market, including Agilent Technologies, Bio-Rad, Danaher Corp., Merck KGaA, Promega Corp. and Thermo Fisher Scientific
Report Scope
This report examines the current and forecasted market potential for metabolomics. It offers a detailed analysis of the market background, technological advancement, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for metabolomics based on product, indication and application type.
By product, the metabolomics market is segmented into separation techniques, detection techniques, assays, and bioinformatics. By indication type, the metabolomics market is segmented into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others. The others segment covers respiratory diseases, infectious diseases, etc. By application, the metabolomics market is segmented into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, and others.
By geography, the metabolomics market has been segmented into Europe, North America, Asia-Pacific (APAC), Latin America, and the Middle East & Africa (MEA). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India, and China are found in the regional segments. For market estimates, data is provided for 2020 as the base year, for 2021 and forecast through year-end 2026. Estimated values used are based on metabolomics companies’ total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Global Markets, Technologies and Materials for Thin and Ultrathin Films (SMC057D)
- Molecular Farming: Global Markets (CHM187A)
- Exosome Diagnostics, Therapeutics and Research Tools: Global Markets (BIO149E)
- Global Skin Allergy Testing Market (MDS104A)
- Global Aircraft Recycling Market (AVM250A)
Report Highlights
The global market for metabolomics should grow from $9.8 billion in 2018 to reach $17.1 billion by 2023 at a compound annual growth rate (CAGR) of 11.9% for the period of 2018-2023.
Report Includes
- 86 data tables and 16 additional tables
- Brief overview and industry analysis of the global markets for metabolomics technologies
- Analyses of global market trends with data from 2016 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Assessment of the key marketed products and recent product launches, regulatory landscape across different demographics covering North America, Europe, Asia-Pacific, Latin America and Middle East
- Examination of the main structure of the metabolomics market by segments, key application areas, and market participants
- Market dynamics and estimated data regarding metabolomics by technological platforms (analytical instruments), detection techniques, separation techniques, assays, disease indication types, applications and geographical regions
- Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
- Detailed profiles of the leading companies in the metabolomics market, including LECO Corp., Metabolon Inc., Shimadzu Corp., Thermo Fisher Scientific Inc., and Waters Corp.
Report Highlights
The global metabolomic market totaled $5.9 billion in 2014 and should total $6.8 billion in 2015 and $12.5 billion by 2020, registering a compound annual growth rate (CAGR) of 13.0%.
Report Includes
- An overview of the commercial potential of the metabolomics research field, the systematic study of the unique chemical fingerprints that cellular processes leaves behind
- Analyses of global market trends, with data from 2014, estimates for 2015 and projections of compound annual growth rates (CAGRs) through 2020
- Definitions of metabolome, metabolites, and metabolomics vs. metabonomics
- Discussion of the conceptual approach in metabolomics: target analysis, metabolite profiling, metabolomics, metabolic fingerprinting
- Examination of the main structure of the metabolomics market: segments, key application areas, and market participants
- Separation techniques for metabolomics: gas chromatography, capillary electrophoresis, and high-performance liquid chromatography (HPLC)
- Patent analysis
- Company profiles of major players in the field
Report Highlights
The global market for metabolomics was valued at $712 million in 2012 and is expect to reach nearly $1.4 billion in 2017, after increasing at a five-year compound annual growth rate (CAGR) of 14.2%.
Report Includes
- An overview of the commercial potential of the metabolomics research field, the systematic study of the unique chemical fingerprints that cellular processes leaves behind
- Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Definitions of metabolome, metabolites, and metabolomics vs. metabonomics
- Discussion of the conceptual approach in metabolomics: target analysis, metabolite profiling, metabolomics, metabolic fingerprinting
- Examination of the main structure of the metabolomics market: segments, key application areas, and market participants
- Separation techniques for metabolomics: gas chromatography, capillary electrophoresis, and high-performance liquid chromatography (HPLC)
- Patent analysis
- Comprehensive company profiles of major players
Related Reports
Bioinformatics: Technologies and Global Markets
The global market for bioinformatics is expected to grow from $18.7 billion in 2023 to $35.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 13.6% during the forecast period of 2023-2028.
Commercial Amino Acids
The global amino acids market was $28.6 billion in 2022 and it should reach $38.8 billion by 2028 from $30.1 billion in 2023 at a compound annual growth rate (CAGR) of 5.2% for the forecast period of 2023 to 2028.
Global Markets and Technologies for Cell and Tissue Analysis
The global cell and tissue analysis market should reach $28.9 billion by 2027 from $18.2 billion in 2022 at a compound annual growth rate (CAGR) of 9.6% for the forecast period of 2022 to 2027.
Global Markets for Bioengineered Protein Drugs
The global market for bioengineered protein drugs is estimated to increase from $354.1 billion in 2022 to reach $521.3 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Recent Reports
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Viral Vector and Plasmid DNA: Technologies and Global Markets
The global market for viral vector and plasmid DNA technologies is expected to grow from $2.9 billion in 2023 to $7.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 19.7% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
Flame Retardant Chemicals: Technologies and Global Markets
The global consumption of flame retardant chemicals is estimated to grow from 6.0 billion pounds in 2022 to 7.5 billion pounds in 2027, at a compound annual growth rate (CAGR) of 4.4% for the period of 2022-2027.
Biorefinery Products: Global Markets
The global market for biorefinery products is estimated to increase from $624.7 billion in 2022 to $920.0 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Electric Vehicle Charging: Infrastructure and Global Markets
The global market for wired electric vehicle charging infrastructure is estimated to grow from $24.1 billion in 2022 to $81.1 billion in 2027, at a compound annual growth rate (CAGR) of 27.4% for the period of 2022-2027.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More